Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Faculty Members have conducted research related to the Global, Regional and National Burden of Testicular Cancer, 1990–2016: Results From the Global Burden of Disease Study 2016
Erfan Amini
Erfan Amini

Associate Professor of Endourology

Department Urology

School of Medicine

Imam Khomeini Hospital Complex

Tehran University of Medical Sciences

Related Documents
1. Global, Regional and National Burden of Testicular Cancer, 1990–2016: Results From the Global Burden of Disease Study 2016, BJU International (2019)
2. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016 a Systematic Analysis for the Global Burden of Disease Study Global Burden of Disease Cancer Collaboration, JAMA Oncology (2018)
3. Healthcare Access and Quality Index Based on Mortality From Causes Amenable to Personal Health Care in 195 Countries and Territories, 1990-2015: A Novel Analysis From the Global Burden of Disease Study 2015, The Lancet (2017)
4. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study, JAMA Oncology (2019)
5. National and Subnational Mortality of Urological Cancers in Iran, 1990–2015, Asia-Pacific Journal of Clinical Oncology (2019)
6. Global, Regional, and National Incidence, Prevalence, and Years Lived With Disability for 328 Diseases and Injuries for 195 Countries, 1990-2016: A Systematic Analysis for the Global Burden of Disease Study 2016, The Lancet (2017)
7. Global, Regional, and National Disability-Adjusted Life-Years (Dalys) for 333 Diseases and Injuries and Healthy Life Expectancy (Hale) for 195 Countries and Territories, 1990-2016: A Systematic Analysis for the Global Burden of Disease Study 2016, The Lancet (2017)
8. Global, Regional, and National Age-Sex Specific Mortality for 264 Causes of Death, 1980–2016: A Systematic Analysis for the Global Burden of Disease Study 2016, The Lancet (2017)
9. Global, Regional, and National Age-Sex-Specific Mortality for 282 Causes of Death in 195 Countries and Territories, 1980–2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
10. Global, Regional, and National Disability-Adjusted Life-Years (Dalys) for 359 Diseases and Injuries and Healthy Life Expectancy (Hale) for 195 Countries and Territories, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
11. Global, Regional, and National Age-Sex-Specific Mortality and Life Expectancy, 1950-2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
12. Measuring Progress From 1990 to 2017 and Projecting Attainment to 2030 of the Health-Related Sustainable Development Goals for 195 Countries and Territories: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
All Documents
1. A Rare Case Report of Muscular Metastasis of Prostate Cancer, Urology Case Reports (2023)
2. Erectile Dysfunction in a Male Patient With Limited Cutaneous Systemic Sclerosis, Urology (2023)
3. Global and Regional Quality of Care Index for Prostate Cancer: An Analysis From the Global Burden of Disease Study 1990–2019, Archives of Public Health (2023)
4. Log Odds of Positive Lymph Nodes (Lodds) As an Independent Predictor of Overall Survival Following Radical Cystectomy in Urothelial Bladder Cancer: Time to Rethink Conventional Node Staging, Clinical Genitourinary Cancer (2023)
5. National and Subnational Incidence Trend of Bladder Cancer in Iran: Report of a 12-Year Period, International Journal of Cancer Management (2023)
6. Trends in Incidence of Prostate Cancer in Iran and Its 31 Provinces During 2003 - 2016, International Journal of Cancer Management (2023)
7. Ultrasound Evaluation of Mid-Urethral Sling Position: A Potential Predictor of Outcomes and Adverse Effects, Gynecologic and Obstetric Investigation (2023)
8. Upper Tract Urothelial Carcinoma (Utuc) Diagnosis and Risk Stratification: A Comprehensive Review, Cancers (2023)
9. A Global, Regional, and National Survey on Burden and Quality of Care Index (Qci) of Bladder Cancer: The Global Burden of Disease Study 1990–2019, PLoS ONE (2022)
10. Association Between Preoperative De Ritis (Ast/Alt) Ratio and Oncological Outcomes Following Radical Cystectomy in Patients With Urothelial Bladder Cancer, Clinical Genitourinary Cancer (2022)
11. Effect of Treatment Modality on Quality of Life Among Patients With Urinary Bladder Cancer, International Journal of Urological Nursing (2022)
12. Evaluation of Direct Intramural Injection to the Bladder Wall As a Method for Developing Orthotopic Tumor Models, Animal Models and Experimental Medicine (2022)
13. Feasibility, Safety, and Effectiveness of Adult-Sized Instruments in Pediatric Percutaneous Nephrolithotomy: A Systematic Review and Meta-Analysis, Journal of Pediatric Urology (2022)
14. Fruhis Significantly Increases the Anti-Benign Prostatic Hyperplasia Effect of Lycopene: A Double-Blinded Randomized Controlled Clinical Trial, Frontiers in Nutrition (2022)
15. Medical Treatment in Men With Infertility Can Be Misinterpreted As Doping Practice: A Case of Unintentional World Anti-Doping Agency (Wada) Code Violation, Asian Journal of Sports Medicine (2022)
16. Radical Cystectomy, Bilateral Lymphadenectomy and Native Ureteral Ligation in a Patient With History of Kidney Transplantation, Journal of Surgical Case Reports (2022)
17. Renal Mucormycosis Following Transurethral Resection of Prostate in the Time of Covid-19: Unique Imaging Features Resembling Emphysematous Pyelonephritis, Urology Case Reports (2022)
18. The Burden of Prostate Cancer in North Africa and Middle East, 1990–2019: Findings From the Global Burden of Disease Study, Frontiers in Oncology (2022)
19. The Burden of Prostate Cancer in North Africa and Middle East, 1990–2019: Findings From the Global Burden of Disease Study, Frontiers in Oncology (2022)
20. A Possible Protective Role for Bacillus Calmette-Guerin Therapy in Urinary Bladder Cancer in the Era of Covid-19: A Brief Report, Clinical and Experimental Vaccine Research (2021)
21. A Prospective Study on [68Ga]-Psma Pet/Ct Imaging in Newly Diagnosed Intermediate-And High-Risk Prostate Cancer, Asia Oceania Journal of Nuclear Medicine and Biology (2021)
22. Adjuvant Vs. Salvage Radiation Therapy After Radical Prostatectomy: Role of Decipher® in the Era of Personalized Medicine, Urology Journal (2021)
23. Effects of Admission Age and Gleason Score on the State Transition in Elderly Patients With Prostate Cancer Using a Multi-State Model, Iranian Journal of Ageing (2021)
24. Effects of Androgen Deprivation Therapy on Covid-19 in Patients With Prostate Cancer: A Systematic Review and Meta-Analysis, Urology Journal (2021)
25. Global, Regional and National Burden of Bladder Cancer and Its Attributable Risk Factors in 204 Countries and Territories, 1990-2019: A Systematic Analysis for the Global Burden of Disease Study 2019, BMJ Global Health (2021)
26. Indirect Factors Affecting Fertility in the Era of Covid-19, Urology Journal (2021)
27. Management of Primary Ewing Sarcoma of the Kidney With Inferior Vena Cava (Ivc) Tumor Thrombosis, Urology Case Reports (2021)
28. Metastatic Involvement of Penis From Colon Cancer: Magnetic Resonance Imaging Features, Urology Case Reports (2021)
29. Primary Squamous Cell Carcinoma of Renal Parenchyma: Case Report and Review of Literature, Urology Case Reports (2021)
30. Renal Ewing's Sarcoma With the Spread of Tumor Thrombosis to the Inferior Vena Cava: Case Report, Tehran University Medical Journal (2021)
31. The Potential of T Cell Immunoglobulin and Mucin-Domain Containing-3 (Tim-3) in Designing Novel Immunotherapy for Bladder Cancer, Endocrine# Metabolic and Immune Disorders - Drug Targets (2021)
32. The Role of Nutritional Interventions in Prostate Cancer: A Review, Journal of Research in Medical Sciences (2021)
33. Financial Burden of Prostate Cancer Screening: Changing Trends After Health Sector Reform in a Developing Country, Urology Journal (2020)
34. Investigation of the Relationship Between Prostate Specific Antigen Doubling Time and the Severity of a Malignant Tumor of the Prostate, Tehran University Medical Journal (2020)
35. Resolution of Hydronephrosis in Children With Dysfunctional Voiding After Biofeedback Therapy: A Randomized Clinical Trial, Applied Psychophysiology Biofeedback (2020)
36. Role of Chronic Inflammation As a Predictor of Upstaging/Upgrading in Prostate Cancer: Finding a New Group Eligible for Active Surveillance, Urology Journal (2020)
37. Serum and Urine Levels of Vascular Endothelial Growth Factor As Prognostic Markers in Patients With Bladder Cancer, Middle East Journal of Cancer (2020)
38. Urinary Viral Shedding of Covid-19 and Its Clinical Associations: A Systematic Review and Meta-Analysis of Observational Studies, Urology Journal (2020)
39. Urology Practice in the Time of Covid-19, Urology Journal (2020)
40. A Review on the Role of M2 Macrophages in Bladder Cancer; Pathophysiology and Targeting, International Immunopharmacology (2019)
41. Effects of Opium Dependency on Testicular Tissue in a Rat Model: An Experimental Study, Urology Journal (2019)
42. Global, Regional and National Burden of Bladder Cancer, 1990 to 2016: Results From the Gbd Study 2016, Journal of Urology (2019)
43. Global, Regional and National Burden of Testicular Cancer, 1990–2016: Results From the Global Burden of Disease Study 2016, BJU International (2019)
44. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study, JAMA Oncology (2019)
45. Long Term Oncologic Outcome in Patients With Bladder Cancer After Radical Cystectomy: Impact of Carcinoma in Situ in the Era of Neoadjuvant Chemotherapy, International Urology and Nephrology (2019)
46. National and Subnational Mortality of Urological Cancers in Iran, 1990–2015, Asia-Pacific Journal of Clinical Oncology (2019)
47. Prostate Specific Antigen Nadir After Radical Cystoprostatectomy in Patients With Benign Prostatic Tissue: A Benchmark to Define Biochemical Recurrence After Radical Prostatectomy, Urology Journal (2019)
48. Second Transurethral Resection of Bladder Tumor: Is It Necessary in All T1 And/Or High-Grade Tumors?, Urology Journal (2019)
49. Simultaneous Cesarean Section and Radical Nephrectomy With Tumor Thrombectomy During Pregnancy, Acta Medica Iranica (2019)
50. Value of Urinary Carbohydrate Antigen 19–9 to Predict Failure of Conservative Management in Children With Ureteropelvic Junction Obstruction, Journal of Pediatric Surgery (2019)
51. Association Between Race and Oncologic Outcome Following Radical Prostatectomy for Clinically Organ-Confined Prostate Cancer: A Long-Term Follow-Up Study, World Journal of Urology (2018)
52. Erratum: Global, Regional, and National Age-Sex-Specific Mortality for 282 Causes of Death in 195 Countries and Territories, 1980–2017: A Systematic Analysis for the Global Burden of Disease Study 2017 (The Lancet (2018) 392(10159) (1736–1788)(S0140673618322037)(10.1016/S0140-6736(18)32203-7)), The Lancet (2018)
53. Erratum: Global, Regional, and National Age-Sex-Specific Mortality for 282 Causes of Death in 195 Countries and Territories, 1980–2017: A Systematic Analysis for the Global Burden of Disease Study 2017 (The Lancet (2018) 392(10159) (1736–1788)(S0140673618322037)(10.1016/S0140-6736(18)32203-7)), The Lancet (2018)
54. Feasibility and Safety of Ultrasonography Guidance and Flank Position During Percutaneous Nephrolithotomy, Journal of Urology (2018)
55. Global, Regional and National Burden of Prostate Cancer, 1990 to 2015: Results From the Global Burden of Disease Study 2015, Journal of Urology (2018)
56. Global, Regional, and National Age-Sex-Specific Mortality and Life Expectancy, 1950-2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
57. Global, Regional, and National Age-Sex-Specific Mortality and Life Expectancy, 1950-2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
58. Global, Regional, and National Age-Sex-Specific Mortality for 282 Causes of Death in 195 Countries and Territories, 1980–2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
59. Global, Regional, and National Age-Sex-Specific Mortality for 282 Causes of Death in 195 Countries and Territories, 1980–2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
60. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016 a Systematic Analysis for the Global Burden of Disease Study Global Burden of Disease Cancer Collaboration, JAMA Oncology (2018)
61. Global, Regional, and National Disability-Adjusted Life-Years (Dalys) for 359 Diseases and Injuries and Healthy Life Expectancy (Hale) for 195 Countries and Territories, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
62. Global, Regional, and National Disability-Adjusted Life-Years (Dalys) for 359 Diseases and Injuries and Healthy Life Expectancy (Hale) for 195 Countries and Territories, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
63. Measuring Progress From 1990 to 2017 and Projecting Attainment to 2030 of the Health-Related Sustainable Development Goals for 195 Countries and Territories: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
64. Measuring Progress From 1990 to 2017 and Projecting Attainment to 2030 of the Health-Related Sustainable Development Goals for 195 Countries and Territories: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
65. Evolution and Patterns of Global Health Financing 1995-2014: Development Assistance for Health, and Government, Prepaid Private, and Out-Of-Pocket Health Spending in 184 Countries, The Lancet (2017)
66. Future and Potential Spending on Health 2015-40: Development Assistance for Health, and Government, Prepaid Private, and Out-Of-Pocket Health Spending in 184 Countries, The Lancet (2017)
67. Global, Regional, and National Age-Sex Specific Mortality for 264 Causes of Death, 1980–2016: A Systematic Analysis for the Global Burden of Disease Study 2016, The Lancet (2017)
68. Global, Regional, and National Comparative Risk Assessment of 84 Behavioural, Environmental and Occupational, and Metabolic Risks or Clusters of Risks, 1990-2016: A Systematic Analysis for the Global Burden of Disease Study 2016, The Lancet (2017)
69. Global, Regional, and National Disability-Adjusted Life-Years (Dalys) for 333 Diseases and Injuries and Healthy Life Expectancy (Hale) for 195 Countries and Territories, 1990-2016: A Systematic Analysis for the Global Burden of Disease Study 2016, The Lancet (2017)
70. Global, Regional, and National Incidence, Prevalence, and Years Lived With Disability for 328 Diseases and Injuries for 195 Countries, 1990-2016: A Systematic Analysis for the Global Burden of Disease Study 2016, The Lancet (2017)
71. Global, Regional, and National Under-5 Mortality, Adult Mortality, Age-Specific Mortality, and Life Expectancy, 1970-2016: A Systematic Analysis for the Global Burden of Disease Study 2016, The Lancet (2017)
72. Healthcare Access and Quality Index Based on Mortality From Causes Amenable to Personal Health Care in 195 Countries and Territories, 1990-2015: A Novel Analysis From the Global Burden of Disease Study 2015, The Lancet (2017)
73. Long-Term Complications of Urinary Diversion, Urinary Diversion (2017)
74. Oncological Outcomes After Radical Prostatectomy for High-Risk Prostate Cancer Based on New Gleason Grouping System: A Validation Study From University of Southern California With 3,755 Cases, Prostate (2017)
75. Supernumerary Kidney Associated With Horseshoe Malformation: A Case Report and Review of Literature, Urology Case Reports (2017)
76. Is There a Role for Genetic Information in Risk Assessment and Decision Making in Prostate Cancer?, Nephro-Urology Monthly (2016)
77. Is There a Role for Urodynamic Study in Women With Urinary Incontinence?, Urology Journal (2016)
78. Re: The Timing of Radical Cystectomy for Bacillus Calmette-Guerin Failure: Comparison of Outcomes and Risk Factors for Prognosis: C. R. Haas, L. J. Barlow, G. M. Badalato, G. J. Decastro, M. C. Benson and J. M. Mckiernan J Urol 2016; 195: 1704–1709., Journal of Urology (2016)
79. The Role of Serum and Urinary Carbohydrate Antigen 19-9 in Predicting Renal Injury Associated With Ureteral Stone, Renal Failure (2016)
80. Unique Imaging Features of Renal Arteriopelvic Fistula on Contrast-Enhanced Multidetector Computed Tomography, Urology (2016)
81. Applying Extender Devices in Patients With Penile Dysmorphophobia: Assessment of Tolerability, Efficacy, and Impact on Erectile Function, Journal of Sexual Medicine (2015)
82. Assessment of Testicular Perfusion Prior to Sperm Extraction Predicts Success Rate and Decreases the Number of Required Biopsies in Patients With Non-Obstructive Azoospermia, International Urology and Nephrology (2015)
83. Long-Term Complications of Urinary Diversion, Current Opinion in Urology (2015)
84. Postchemotherapy Retroperitoneal Lymph Node Dissection in Patients With Nonseminomatous Testicular Cancer: A Single Center Experiences, Nephro-Urology Monthly (2015)
85. Transition Zone Prostate Specific Antigen Density Improves Prostate Cancer Detection in Iranian Men, Nephro-Urology Monthly (2015)
86. Transition Zone Prostate-Specific Antigen Density Could Better Guide the Rebiopsy Strategy in Men With Prostate Inflammation at Initial Biopsy, Urology (2015)
87. Unusual Presentation of Renal Cell Carcinoma in Crossed Ectopic Kidney, Nephro-Urology Monthly (2015)